Stock GRPH LENZ THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Sector Chart LENZ Therapeutics, Inc. OTC Markets

Equities

GRPH

US52635N1037

Real-time Estimate Cboe BZX
Other stock markets
 14:43:54 2024-05-14 EDT 		5-day change 1st Jan Change
15.58 USD -30.03% Intraday chart for LENZ Therapeutics, Inc. -4.79% +21.37%
04-15 Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target MT
04-15 William Blair Starts LENZ Therapeutics With Outperform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 22.34B -
ARGENX SE Stock argenx SE
 21.93B -
GENMAB A/S Stock Genmab A/S
 18.59B
  1. Stock Market
  2. Equities
  3. LENZ Stock
  4. GRPH Stock
  5. Charts LENZ Therapeutics, Inc.
  6. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW